GO
Loading...

U.S. News

More

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • A new class of drugs which aim to lower levels of LDL are being pursued by multiple pharma companies and it could be a $10 billion market. Leonard Schleifer, Regeneron CEO, discusses what is known about bad cholesterol, and competition in the space.

  • Jeremy Siegel, Wharton School Professor of Finance, shares his view of the U.S. economy and market trends.

  • Atlantic City's $2.4 billion Revel casino has officially closed, with CNBC's Morgan Brennan.